SYK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Stryker Corporation

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Stryker Corporation (“Stryker”) (NYSE:SYK) violated federal securities laws.

Click here to learn about the case: http://docs.wongesq.com/SYK-Info-Request-Form-1693. There is no cost or obligation to you.

On July 17, 2017, the U.S. Food and Drug Administration issued a warning letter to Stryker citing “violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals.” Then on August 23, 2017, Stryker Corporation announced a “voluntary product recall involving specific lots of Oral Care products sold through the company’s Sage Products business unit (Sage).” The recall is due to a potential for “cross-contamination of Oral Care solutions” by a third-party supplier.

To learn more about the investigation of Stryker contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/SYK-Info-Request-Form-1693.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170831006380/en/